Among the gene-expression signatures with
the greatest promise are those derived from
stem cells and progenitor cells.18,19 Therefore, we
initiated a systematic search for a biomarker
that could be used to identify undifferentiated
tumors (i.e., tumors depleted of cells with a
mature phenotype) by means of immunohistochemical
analysis.